Clinical Trial Update: Open Label Study With OHR/AVR118 in Advanced Cancer Patients With Anorexia-Cachexia [Phase 2]

View source ↗

Summary

Open-label Phase 2 trial of OHR/AVR118 in advanced cancer patients with anorexia-cachexia; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Cachexia

Drugs mentioned

• OHR/AVR118

Snippet

Sponsor: Ohr Pharmaceutical Inc. | Conditions: Anorexia, Cancer Cachexia | Phase 2 | Status: UNKNOWN